Pharmaceutical Cold Chain Risks and How to Mitigate Them
Shipping temperature sensitive pharmaceuticals involves a range of risks that can impact the quality, safety, and availability of live saving treatments for patients. Nick Gilmore, Global Head of Sales and Marketing of Tower Cold Chain, explores how risk can be mitigated through strategic partnerships with specialist temperature-controlled packaging suppliers.
The pharmaceutical industry is growing at a rapid rate, and as the most current data from Statistica has demonstrated, it has now surpassed the $1.48 trillion mark in revenue. With such growth comes an increased level of complexity in the pharmaceutical supply chain, and thus the reason why implementing best practices for managing risk is crucial.
Securing the integrity and quality of medical and biological products during transportation stands as a pivotal challenge for both pharmaceutical manufacturers and logistics providers. With many biopharmaceuticals requiring strict temperature control from manufacturer to patient, precise handling and storage is essential. The potential loss of cargo poses a significant risk to patient health and wellness. Coupled with increasing regulatory requirements whilst serving an international market, players need to implement robust quality assurance practices to mitigate these risks and ensure products are transported reliably across the supply chain.
Check out our full article: https://international-pharma.com/pharmaceutical-cold-chain-risks-and-how-to-mitigate-them/
